|
|
||||||||
Ann Thorac Surg 1997;64:142-147
© 1997 The Society of Thoracic Surgeons
Section of Cardiac and Thoracic Surgery, Temple University Health Sciences Center, Philadelphia, Pennsylvania
Accepted for publication January 20, 1997.
Background. Left ventricular assist devices (LVADs) are being used as bridges to heart transplantation (HT). Infection of the LVAD in this patient population represents a serious complication, as simple LVAD removal or delaying HT may result in death. To improve outcomes in this group of patients, we performed HT in the presence of LVAD infection.
Methods. Eighteen patients underwent LVAD implantation followed by HT. Ten underwent HT in the absence of LVAD infection (group 1); and 8, in the presence of LVAD infection (group 2). All patients were treated similarly except for modification of immunosuppression in group 2 patients.
Results. Infectious and noninfectious complications were equivalent between the two groups. There was no difference between groups in regard to intraoperative deaths (one versus none), long-term survival (8/10 versus 7/8), wound complications (three versus none), and mean length of hospital stay after HT (21 versus 26 days).
Conclusions. Patients with LVAD infection are too seriously ill to allow LVAD removal or delay of HT. Transplantation in the face of infection is an effective treatment option.
This article has been cited by other articles:
![]() |
A. Zierer, S. J. Melby, R. K. Voeller, T. J. Guthrie, G. A. Ewald, K. Shelton, M. K. Pasque, M. R. Moon, R. J. Damiano Jr, and N. Moazami Late-Onset Driveline Infections: The Achilles' Heel of Prolonged Left Ventricular Assist Device Support Ann. Thorac. Surg., August 1, 2007; 84(2): 515 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Simon, S. Fischer, A. Grossman, C. Downer, B. Hota, A. Heroux, and G. Trenholme Left Ventricular Assist Device--Related Infection: Treatment and Outcome Clinical Infectious Diseases, April 15, 2005; 40(8): 1108 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Holman, B. K. Rayburn, D. C. McGiffin, B. A. Foley, R. L. Benza, R. C. Bourge, L. J. Pinderski, and J. K. Kirklin Infection in ventricular assist devices: prevention and treatment Ann. Thorac. Surg., June 1, 2003; 75(90060): S48 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mekontso-Dessap, M. Kirsch, E. Vermes, C. B. Buisson, D. Loisance, and R. Houel Nosocomial Infections Occurring during Receipt of Circulatory Support with the Paracorporeal Ventricular Assist System Clinical Infectious Diseases, December 1, 2002; 35(11): 1308 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Gordon, S. K. Schmitt, M. Jacobs, N. M. Smedira, M. Goormastic, M. K. Banbury, M. Yeager, J. Serkey, K. Hoercher, and P. M. McCarthy Nosocomial bloodstream infections in patients with implantable left ventricular assist devices Ann. Thorac. Surg., September 1, 2001; 72(3): 725 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Vilchez, M. C. McEllistrem, L. H. Harrison, K. R. McCurry, R. L. Kormos, and S. Kusne Relapsing bacteremia in patients with ventricular assist device: an emergent complication of extended circulatory support Ann. Thorac. Surg., July 1, 2001; 72(1): 96 - 101. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |